↳ DNA Capital

When it comes to venture capital and private equity in the healthcare sector, especially in Brazil, DNA Capital is the immediate answer. Its reputation comes from a surgical eye for investments with great potential to transform the health and legacy of the Bueno Family, creators of Amil.

In 2019, DNA took a step further to evolve its entire value proposition. So, we found this essence and transformed into a positioning and a visual identity that could convey all the value of DNA, its expertise and legacy. Thus, in a clear and inspiring way, the brand can connect even more with its stakeholders.